Discover open access scientific publications

Therapy With Atorvastatin Versus Rosuvastatin Reduces Urinary Podocytes, Podocyte-Associated Molecules, and Proximal Tubule Dysfunction Biomarkers in Patients With Type 2 Diabetes Mellitus: A Pilot Study